health biotech news today obesity drugs glp-1 Novartis, Alector, Merck, Alnylm, UniQure : Readout Newsletter ADA '26: Lilly's dominance, Pfizer's

PlexusDx emphasizes precision wellnessleveraging genetic insights to support more informed conversations between patients and their providers about which mechanism class aligns with their unique metabolic biology

Starting a GLP-1 drug (short for glucagon-like peptide-1 receptor agonists), such as semaglutide or tirzepatide, often comes with ups and downs

Direct clinical trial evidence that GLP-1R agonists reduce symptoms and clinical events specifically in patients with coronary microvascular dysfunction is limited

They found that the cost of tirzepatide was about $197,000 per additional quality adjusted life year (QALY), and the cost of semaglutide was about $468,000 per QALY

Hasegawa, Y., Hori, M., Nakagami, T., Harada-Shiba, M

Many people who took Zepbound and drugs like it died or experienced severe complications such as gastroparesis, acute pancreatitis, and thyroid cancer